Cargando…
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
Sublines of the human small-cell lung carcinoma (SCLC) cell line GLC4 with acquired resistance to teniposide, amsacrine and mitoxantrone (GLC4/VM20x, GLC4/AM3x and GLC4/MIT60x, respectively) were derived to study the contribution of DNA topoisomerase II alpha and -beta (TopoII alpha and -beta) to re...
Autores principales: | Withoff, S., de Vries, E. G., Keith, W. N., Nienhuis, E. F., van der Graaf, W. T., Uges, D. R., Mulder, N. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074800/ https://www.ncbi.nlm.nih.gov/pubmed/8980384 |
Ejemplares similares
-
Incidence of Mutation and Deletion in Topoisomerase IIα mRNA of Etoposide and mAMSA–resistant Cell Lines
por: Matsumoto, Yoshihito, et al.
Publicado: (2001) -
A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.
por: West, C., et al.
Publicado: (1981) -
mAMSA resistant human topoisomerase IIβ mutation G465D has reduced ATP hydrolysis activity
por: Gilroy, Kathryn L., et al.
Publicado: (2006) -
Expression of Drug Resistance Genes in VP‐16 and mAMSA‐selected Human Carcinoma Cells
por: Matsumoto, Yoshihito, et al.
Publicado: (2001) -
Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)